Unknown

Dataset Information

0

C-reactive protein levels in patients with amyotrophic lateral sclerosis: A systematic review.


ABSTRACT:

Introduction

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting cortical and spinal motor neurons. There is a lack of optimal biomarkers to diagnose and prognosticate the ALS patients. C-reactive protein (CRP), an inflammatory marker, has shown promising results in ALS patients.

Materials and methods

PubMed, Embase, and Google Scholar databases were searched from 2000 to June 1, 2021 for suitable studies showing the relationship between CRP and ALS. The concentration of CRP levels was assessed between ALS patients and controls. Further, end outcomes like ALS functional rating scale (ALSFRS-R), survival status, and mortality risks were assessed in relation to CRP levels.

Results

Eleven studies including five case-control, five cohorts, and one randomized control study were assessed. There were 2785 ALS patients and 3446 healthy controls. A significant increment in CRP levels among ALS patients in comparison with healthy controls were seen in most of the studies. ALSFRS-R and disease progression were found to be significantly correlated with CRP levels. Overall accuracy of CRP in CSF was 62% described in a single study.

Conclusion

Although CRP has shown promise as a prognostic biomarker, extensive cohort studies are required to assess its prognostic value and accuracy in diagnosing ALS taking into account the confounding factors.

SUBMITTER: Kharel S 

PROVIDER: S-EPMC8933772 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

C-reactive protein levels in patients with amyotrophic lateral sclerosis: A systematic review.

Kharel Sanjeev S   Ojha Rajeev R   Preethish-Kumar Veeramani V   Bhagat Riwaj R  

Brain and behavior 20220224 3


<h4>Introduction</h4>Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting cortical and spinal motor neurons. There is a lack of optimal biomarkers to diagnose and prognosticate the ALS patients. C-reactive protein (CRP), an inflammatory marker, has shown promising results in ALS patients.<h4>Materials and methods</h4>PubMed, Embase, and Google Scholar databases were searched from 2000 to June 1, 2021 for suitable studies showing the relationship between CRP an  ...[more]

Similar Datasets

| S-EPMC7850290 | biostudies-literature
| S-EPMC5784458 | biostudies-literature
| S-EPMC5822215 | biostudies-literature
| S-EPMC4653353 | biostudies-other
2012-07-25 | E-GEOD-39644 | biostudies-arrayexpress
| S-EPMC7593382 | biostudies-literature
2003-11-14 | GSE833 | GEO
2012-07-26 | GSE39644 | GEO
2021-09-20 | E-MTAB-10916 | biostudies-arrayexpress
| S-EPMC7540334 | biostudies-literature